Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue
In 2023, the American Heart Association for the first time formally defined cardiovascular-kidney-metabolic (CKM) syndrome as a systemic disease characterized by pathophysiological interactions between metabolic risk factors, chronic kidney disease (CKD), and cardiovascular system, leading to multip...
Saved in:
Main Authors: | G. G. Arabidze, M. N. Mamedov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2024-06-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome
by: Juan Guerrero-Mauvecin, et al.
Published: (2025-06-01) -
Early-Life Prevention of Cardiovascular–Kidney–Metabolic Syndrome: The DOHaD Perspective on Resveratrol and Short-Chain Fatty Acids
by: Chien-Ning Hsu, et al.
Published: (2025-07-01) -
Climate Vulnerability and Cardiovascular‐Kidney‐Metabolic Disease in the United States
by: Pedro Rafael Vieira de Oliveira Salerno, et al.
Published: (2025-06-01) -
Genetic architecture and mechanisms shared between kidney and ureteral stones, cardiovascular diseases, and metabolic syndrome: A comprehensive GWAS analysis
by: Yibo Hua, et al.
Published: (2025-09-01) -
Association between the dietary inflammatory index and depressive symptoms in adults with cardiovascular–kidney–metabolic syndrome: evidence of metabolic syndrome as a mediator
by: Ruo-Nan Tian, et al.
Published: (2025-07-01)